New drug IY-828026 tested in healthy people for first time
Knowledge-focused
Recruiting now
This early-stage study tests the safety of a new drug called IY-828026 in 86 healthy adults aged 19 to 50. Participants receive either the drug or a placebo to see how the body processes it and if any side effects occur. The goal is to gather important safety and dosing informati…
Phase: PHASE1 • Sponsor: Il-Yang Pharm. Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC